These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4409994)
41. Panel discussion: international drug regulations and their practical application. I. Swedish experience of drug regulations and their applications. Liljestrand A Bull Parenter Drug Assoc; 1974; 28(4):153-60. PubMed ID: 4853527 [No Abstract] [Full Text] [Related]
42. [The new narcotics law]. Becker W Ther Ggw; 1972 Oct; 111(10):1514-34. PubMed ID: 5087287 [No Abstract] [Full Text] [Related]
43. [Physicians and the law of December 31, 1970 relative to prevention of drug addiction]. Doll PJ Presse Med (1893); 1971 Apr; 79(19):877-9. PubMed ID: 5576503 [No Abstract] [Full Text] [Related]
44. Federal response to drug abuse. Heistad GT Minn Med; 1973 Mar; 56(3):187-91. PubMed ID: 4734613 [No Abstract] [Full Text] [Related]
45. [Drug registration in the county of Jämtland: Clinical experiences of the preliminary study in 1968]. Bergström I; Carmstad A; Elwin CE; Heedman PA; Källström B; Westerholm B; Wiman F Lakartidningen; 1970 Jun; 67():Suppl III:91+. PubMed ID: 5478701 [No Abstract] [Full Text] [Related]
46. The Controlled Dangerous Substances Act of 1969. Sonnenreich MR Bull Parenter Drug Assoc; 1970; 24(1):14-22. PubMed ID: 5461193 [No Abstract] [Full Text] [Related]
47. Legal prescription of narcotics. Bellizzi JJ N Y State J Med; 1970 Jun; 70(12):1677-80. PubMed ID: 5267676 [No Abstract] [Full Text] [Related]
48. [The use of tranquilizers]. Gottfries CG; Perris C Lakartidningen; 1973 Feb; 70(6):485-6. PubMed ID: 4683691 [No Abstract] [Full Text] [Related]
49. Patterns, range and effects of misused psychotropic substances in Europe. Idanpaan-Heikkila J Med J Aust; 1973 Sep; 1(6):Suppl 6:39-41. PubMed ID: 4749985 [No Abstract] [Full Text] [Related]
50. [Background and risks of drug use]. Ladee GA Ned Tijdschr Geneeskd; 1972 Jul; 116(28):1192-3. PubMed ID: 5040423 [No Abstract] [Full Text] [Related]
51. [The effect of wekamines on humans]. Sloot HA Pharm Weekbl; 1969 Aug; 104(35):1075-8. PubMed ID: 5806269 [No Abstract] [Full Text] [Related]
52. [Drug addiction, toxicomania. Viewpoints on establishing new measures of control]. Bertschinger P Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):96-103. PubMed ID: 5141146 [No Abstract] [Full Text] [Related]
53. [Misuse of drugs and excess of self-administered drugs. Administrative and legislative problems]. Nargeolet H Therapie; 1972; 27(2):289-95. PubMed ID: 4673513 [No Abstract] [Full Text] [Related]
54. [WHO stopped Swedish action against central stimulating agents]. Lakartidningen; 1968 Jun; 65(23):2620-1. PubMed ID: 5721508 [No Abstract] [Full Text] [Related]
55. The role of the federal government in the development of narcotic antagonists. Green AI Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123 [No Abstract] [Full Text] [Related]
57. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
58. Control of amphetamines in the Republic of Ireland. Timoney RF J Ir Med Assoc; 1972 Feb; 65(3):57-61. PubMed ID: 5060442 [No Abstract] [Full Text] [Related]
59. A perspective from the United Nations. Ling G Ann Ist Super Sanita; 1982; 18(4):695-7. PubMed ID: 7188526 [No Abstract] [Full Text] [Related]
60. Abuse to hypnotics. McKim TR Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):381-3. PubMed ID: 5750142 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]